Jushi Holdings Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

ACQUISITIONS - Narrative (Details)

ACQUISITIONS - Narrative (Details)				1 Months Ended					2 Months Ended	3 Months Ended	9 Months Ended
ACQUISITIONS - Narrative (Details)	Sep. 10, 2021 USD ($) ft² dispensary $ / shares shares	Apr. 30, 2021 USD ($)	Mar. 04, 2021 USD ($) $ / shares shares	Sep. 30, 2022 USD ($)	Jul. 31, 2022 USD ($) shares	Apr. 30, 2022 USD ($) $ / shares shares	Mar. 31, 2022 USD ($) $ / shares shares	Jul. 31, 2021 USD ($) ft²	Apr. 30, 2022 USD ($) $ / shares	Sep. 30, 2022 USD ($)	Sep. 30, 2022 USD ($)	Sep. 09, 2022	Dec. 31, 2021 USD ($)	Jul. 31, 2021 a
Business Acquisition [Line Items]
Contingent consideration liabilities - current portion				$ 3,253,000						$ 3,253,000	$ 3,253,000		$ 0
Contingent consideration liabilities - non-current				1,418,000						1,418,000	1,418,000		$ 8,223,000
OhiGrow Assets Acquisition
Business Acquisition [Line Items]
Area of real estate property (in sq ft)								10,000						1.35
Consideration paid in cash, as adjusted for working capital adjustments								$ 4,949,000
Grover Beach Assets Acquisition
Business Acquisition [Line Items]
Consideration paid in cash, as adjusted for working capital adjustments			$ 3,592,000
Equity acquired			78.00%									22.00%
Equity interest issued and issuable (in shares) \| shares			49,348
Equity issued, price per share (in dollars per share) \| $ / shares			$ 7.46
Rights to remaining equity			$ 1
Second Milestone Period
Business Acquisition [Line Items]
Contingent liability				4,671,000						4,671,000	4,671,000
NuLeaf
Business Acquisition [Line Items]
Equity interests acquired						100.00%			100.00%
Consideration paid in cash, as adjusted for working capital adjustments						$ 14,918,000
Equity issued (in shares) \| shares						4,662,384
Equity issued, price per share (in dollars per share) \| $ / shares						$ 2.91			$ 2.91
Debt instrument term					5 years	5 years
Consideration payable in cash (customary hold back liability)						$ 1,000,000
Contingent liability						10,000,000			$ 10,000,000
Contingent liability, cash						3,000,000			3,000,000
Contingent liability, additional debt						3,000,000			3,000,000
Payment for contingent consideration liability					$ 3,000,000
Payment for contingent consideration liability, net					$ 2,657,000
Equity interest issued to settle contingent liability (in shares) \| shares					888,880
Equity interest issued to settle contingent liability					$ 1,529,000
Contingent consideration liabilities - current portion						7,989,000			7,989,000
NuLeaf \| Nuleaf Unsecured Promissory Notes \| Acquisition-related promissory notes payable
Business Acquisition [Line Items]
Debt instrument principal amount						15,750,000			15,750,000
Apothecarium
Business Acquisition [Line Items]
Equity interests acquired							100.00%
Consideration paid in cash, as adjusted for working capital adjustments							$ 6,617,000
Equity issued (in shares) \| shares							527,704
Equity issued, price per share (in dollars per share) \| $ / shares							$ 3.02
Debt instrument term							5 years
Consideration payable in cash (customary hold back liability)							$ 0
Consideration paid in promissory notes (fair value)							9,853,000
Contingent consideration liabilities - current portion							$ 0
Apothecarium and NuLeaf
Business Acquisition [Line Items]
Acquisition related costs										0	1,184,000
Nature's Remedy
Business Acquisition [Line Items]
Equity interests acquired	100.00%
Equity issued (in shares) \| shares	8,700,000
Equity issued, price per share (in dollars per share) \| $ / shares	$ 4.10
Contingent liability	$ 8,223,000
Payment for contingent consideration liability					$ 5,000,000
Number of retail dispensaries \| dispensary	2
Area of real estate property (in sq ft) \| ft²	50,000
Contingent consideration, equity interest issued and issuable	$ 5,000,000
Minimum contingent consideration	0
Maximum contingent consideration	$ 10,800,000
Contingent consideration liabilities - current portion				3,253,000						3,253,000	3,253,000
Contingent consideration liabilities - non-current				$ 1,418,000						1,418,000	1,418,000
Nature's Remedy \| First Milestone Period
Business Acquisition [Line Items]
Contingent consideration period	12 months
Nature's Remedy \| Second Milestone Period
Business Acquisition [Line Items]
Contingent consideration period	18 months
Nature's Remedy \| Nature's Remedy Three-Year Note
Business Acquisition [Line Items]
Debt instrument term	3 years			3 years
Contingent liability, additional debt	$ 5,000,000			$ 5,000,000						5,000,000	5,000,000
Consideration paid in promissory notes (fair value)	$ 11,500,000
Maximum contingent consideration, net				$ 4,708,000						4,708,000	4,708,000
Nature's Remedy \| Nature's Remedy Five-Year Note
Business Acquisition [Line Items]
Debt instrument term	5 years
Consideration paid in promissory notes (fair value)	$ 5,000,000
Organic Solutions of the Desert, LLC
Business Acquisition [Line Items]
Equity interests acquired		100.00%
Consideration paid in promissory notes (fair value)		$ 3,100,000
2022 Business Combinations
Business Acquisition [Line Items]
Consideration paid in cash, as adjusted for working capital adjustments									21,535,000
Consideration payable in cash (customary hold back liability)									1,000,000
Contingent consideration liabilities - current portion						$ 7,989,000			$ 7,989,000
Contributed revenues										9,478,000	19,042,000
Contributed net income										(1,018,000)	(1,829,000)
2021 Business Combinations and Asset Acquisitions
Business Acquisition [Line Items]
Contributed revenues										3,127,000	3,619,000
Contributed net income										$ (400,000)	$ (459,000)